Polymyositis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2025-07-17
Clinical Trial Update: Study of M5049 in DM and PM Participants (NEPTUNIA) [Phase 2]
A Phase 2 trial (NEPTUNIA) evaluating M5049 for Dermatomyositis and Polymyositis has been terminated.